← Leaderboards
Sergei R Malkhosyan
Burnham Institute For Medical Research
$3,198,332
Attributed
$3,198,332
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $568.1K · FY2005–07$1M$750K$500K$250K$0
'05
'06
'07
Funding mix
By agency
NIH$3,198,332 · 3
By mechanism
R33$3,003,371 · 2
R21$194,961 · 1
Top collaborators
No co-investigators on record.
Most similar at Burnham Institute For Medical Research
Same institution · by research overlap
- Manuel Perucho$10,003,324
- Fumiichiro Yamamoto$2,003,128
Others in their field
Top investigators on “Neoplasm /Cancer Genetics”
- Gregory H Reaman · National Childhood Cancer Foundation$112,559,481
- Charles A Coltman · Southwest Oncology Group$46,831,444
- Samuel A Wells · Duke University$32,148,803
- David Sidransky · Johns Hopkins University$27,906,864
- Brian E Henderson · University Of Southern California$27,493,155
- Bruce W Stillman · Cold Spring Harbor Laboratory$22,532,365
Research focus
Neoplasm /Cancer GeneticsGenomeFluorescent Dye /ProbeOligonucleotidesNucleic Acid HybridizationMicroarray TechnologyBiopsyHuman TissueRestriction Fragment Length PolymorphismPolymerase Chain ReactionBreast Neoplasm /Cancer DiagnosisCellsCell Transformation, NeoplasticCharacteristicsCell GrowthBreast Cancer DiagnosisBehaviorCancer RecurrenceComparativeCollectionCorrelation StudiesDensityDetectionCancer Genome
Grant awards (7)
Molecular Genomics of Breast Cancer$555,780
R33 · FY2007 · CA · contact PI
Molecular Genomics of Breast Cancer$555,707
R33 · FY2006 · CA · contact PI
Molecular Genomics of Breast Cancer$568,119
R33 · FY2005 · CA
COMPARATIVE HYBRIDIZATION OF AP PCR ARRAYS$520,353
R33 · FY2003 · CA
COMPARATIVE HYBRIDIZATION OF AP PCR ARRAYS$406,206
R33 · FY2002 · CA
COMPARATIVE HYBRIDIZATION OF AP PCR ARRAYS$397,206
R33 · FY2001 · CA
COMPARATIVE HYBRIDIZATION OF AP PCR ARRAYS$194,961
R21 · FY2000 · CA